Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in
elderly people globally. It is estimated that there will be more Asians with AMD than the rest …

Large submacular hemorrhage, an uncommon manifestation of neovascular age-related
macular degeneration, may also occur with idiopathic polypoidal choroidal vasculopathy …

For years, branch retinal vein occlusion is still a controversial disease in many aspects. An
increasing amount of data is available regarding classification, pathogenesis, risk factors …

Objective We aimed to compare visual and anatomical outcome in subretinal aflibercept vs.
intravitreal aflibercept in the context of Pars Plana Vitrectomy (PPV), pneumatic …

Objective To compare efficacy and safety profile of subretinal aflibercept, ranibizumab, and
bevacizumab in the context of pars plana vitrectomy, pneumatic displacement with …

Purpose To present the initial multicenter experience of using subretinal air injection in
combination with tissue plasminogen activator (tPA) at the time of pars plana vitrectomy …

Purpose: Current management of submacular hemorrhage (SMH) favors vitrectomy and gas
with subretinal administration of recombinant tissue plasminogen activator (rtPA) over mere …

Submacular hemorrhage (SMH) is the accumulation of blood in the macular area that can
severely damage the macular structure and visual function. Recently, the intraocular …

Purpose Contradictory evidence exists over the best approach for the management of
submacular hemorrhage (SMH). In this study, we compared the outcomes of subretinal …

Age-related macular degeneration (AMD) is the leading cause of irreversible vision loss
among individuals aged 65 years and older in the USA. For individuals diagnosed with …